Robocath has announced the success of its first two coronary angioplasties performed with assistance from its R-One robotic platform. The procedures were performed in France at Rouen University Hospital by Eric Durand and Rémi Sabatier, and at Clinique Pasteur in Toulouse by Jean Fajadet.

According to a press release, R-One assists interventional cardiologists in performing coronary angioplasties. The robotic platform is designed to facilitate and enhance interventional procedures performed for the patient and offers a better working environment for physicians and the entire medical team. The press release states that this prospective clinical study is the first of its kind to be conducted in Europe. It involves six European centres, three of which are based in France (Rouen University Hospital, Caen University Hospital, Clinique Pasteur in Toulouse). The study will involve 60 patients and aims to demonstrate the safety and efficacy of the robotic-assisted platform R-One in coronary angioplasties.

Philippe Bencteux, president and founder of Robocath, says: “These two successes mark a new era in the way interventional cardiology is practiced in Europe today. It is a project we have worked on for several years and the entire team and I are extremely proud of the success of these two procedures.”

Fajadet (Clinique Pasteur, Toulouse, France) comments: “I am very happy with the success of these procedures and confident regarding the study results. We are on the cusp of a major revolution in the field of interventional cardiology, thanks to the possibilities opened up by vascular robotics that we are developing at Clinique Pasteur.”